Eco Animal Health grants share awards to executive directors

London - Eco Animal Health Group plc, a veterinary products company, recently granted share options and restricted share units to its top executives, according to a press release. The Long Term Incentive Plan awarded 404,526 ordinary shares, representing about 0.60% of the issued share capital. CEO David Hallas received options for 232,449 shares, while CFO Chris Wilks received options for 172,077 shares.

Both awards are contingent upon meeting performance targets related to Total Shareholder Return and Research and Development, with vesting after three years. Additionally, Eco Animal Health provided restricted share units for 50,566 shares (0.07% of issued capital), with 29,056 RSUs granted to Hallas and 21,510 RSUs to Wilks. These RSUs will also vest after three years but without performance conditions.

The nominal cost for all awards was set at 5 pence per share and were granted on September 9, 2026, in off-market transactions. Eco Animal Health, based in the UK, employs over 200 people globally and offers products like Aivlosin, an antibiotic for livestock, and ECOVAXXIN MS, a poultry vaccine launched in July 2026.